danthron has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
danthron: structure
chrysazin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, C | 1 |
| Wang, Z | 1 |
| Xia, R | 1 |
| Wei, L | 1 |
| Zhang, C | 1 |
| Zhang, J | 1 |
| Zhao, L | 1 |
| Wu, H | 1 |
| Kang, L | 1 |
| Yang, S | 1 |
1 other study available for danthron and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.
Topics: 3T3-L1 Cells; AMP-Activated Protein Kinases; Animals; Anthraquinones; Anti-Obesity Agents; Diet, Hig | 2021 |